News item
Concerns regarding the public health risks associated with unapproved peptide products
Australia’s health leaders are increasingly concerned about the growing availability, promotion and use of unapproved peptide products in Australia.
This is for Doceo members
Membership is free. Join in a minute, or log in if you’re already a member.